Ranitidine bismuth citrate

Overview

Ranitidine bismuth citrate is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine bismuth citrate antagonizes Histamine ( HY-B1204 )-induced increases of the guinea-pig isolated rat atrium and Histamine -induced relaxations of the rat isolated uterine horn, with pA 2 values of 7.2 and 6.95, respectively. Ranitidine bismuth citrate has selectivity for SARS-CoV-2 -infected cells. Ranitidine bismuth citrate also has anti- Helicobacter pylori infection . Ranitidine bismuth citrate inhibits breast tumor development and spread in mice.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Metabolic Disease | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Histamine Receptor | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-B0693A
• CAS No.: 128345-62-0
• Molecular Formula: C19H27BiN4O10S
• Molecular Weight: 712.48
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source